Concordance with final pathology when transitioning from standard transrectal to cognitive targeted transperineal prostate biopsy by Alfred Honoré, Karsten Gravdal, Patrick Juliebø‐Jones, Lars Anders Rokne Reisæter, Christian Beisland, Christian Arvei Moen

Subjects: Get full text

Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study by David H Brewster, Victoria Cairnduff, Eila Watson, Amy Downing, Adam W Glaser, Penny Wright, William Cross, Conan Donnelly, Anna Gavin, Carol Rivas, Richard Wagland, Peter Selby, Luke Hounsome, Therese Kearney, Rebecca Mottram, Majorie Allen, Oonagh McSorley, Hugh Butcher, Paul Kind, James W H Catto, Dyfed Huws, Emma McNair, Lauren Matheson, Johana Nayoan, Mike Horton, Jessica Corner, Julia Verne

“…The Life After Prostate Cancer Diagnosis (LAPCD) study is a UK-wide patient-reported outcomes study which will generate information to improve the health and well-being of men with prostate cancer.Methods and analysis Postal surveys will be sent to prostate cancer survivors (18–42 months postdiagnosis) in all 4 UK countries (n=∼70 000). …”
Get full text

Corrigendum to “Amiodarone Induced Hyponatremia Masquerading as Syndrome of Inappropriate Antidiuretic Hormone Secretion by Anaplastic Carcinoma of Prostate” by Pinaki Dutta, Girish Parthan, Anuradha Aggarwal, Santosh Kumar, Nandita Kakkar, Anil Bhansali, Fabio Rotondo, Kalman Kovacs

Get full text

Associations among immunophenotype, plasma metabolites, and benign prostatic hyperplasia: a mediation Mendelian randomization study by FAN Jiuming, ZHAO Yiqiao, JIA Haichang, WANG Tiankun, HAN Yutong, QIN Zihao, CHEN Ping, ZENG Xiantao

Subjects: “…benign prostatic hyperplasia…”
Get full text

Co-modulation of a circular form of PCDH11Y during neuroendocrine differentiation of prostate cancer by Giovanni Pecoraro, Ilaria Leone, Silvia Nuzzo, Santiago Negueruela, Giovanni Smaldone, Lorena Buono

Subjects: Get full text

Haralick Texture Analysis for Differentiating Suspicious Prostate Lesions from Normal Tissue in Low-Field MRI by Dang Bich Thuy Le, Ram Narayanan, Meredith Sadinski, Aleksandar Nacev, Yuling Yan, Srirama S. Venkataraman

Subjects: Get full text

Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients by Gati K. Panigrahi, Prakash P. Praharaj, Hiroki Kittaka, Asit R. Mridha, Olen M. Black, Rakesh Singh, Roger Mercer, Adrie van Bokhoven, Kathleen C. Torkko, Chapla Agarwal, Rajesh Agarwal, Zakaria Y. Abd Elmageed, Hariom Yadav, Santosh K. Mishra, Gagan Deep

Subjects: Get full text

Somatic Mitochondrial DNA Point Mutations Used as Biomarkers to Demonstrate Genomic Heterogeneity in Primary Prostate Cancer by Christian Arstad, Kristin Taskén, Paulo Refinetti, Ulrika Axcrona, Karl-Erik Giercksky, Per Olaf Ekstrøm

“…Prostate Cancer…”
Get full text

Focal therapy of prostate cancer: Use of artificial intelligence to define tumour volume and predict treatment outcomes by Wayne G. Brisbane, Alan M. Priester, Anissa V. Nguyen, Mark Topoozian, Sakina Mota, Merdie K. Delfin, Samantha Gonzalez, Kyla P. Grunden, Shannon Richardson, Shyam Natarajan, Leonard S. Marks

Subjects: Get full text

Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging of a Patient with Squamous Cell Carcinoma of Prostate by Gonca Kara Gedik, Guler Yavas, Murat Akand, Esin Celik, Oktay Sari

“…Fine needle biopsy from prostate was suspicious of squamous cell carcinoma of the prostate. …”
Get full text

Corrigendum to “Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy” by Katherine Neubecker, Beverley Adams-Huet, Irfan M. Farukhi, Rosinda Castanon, Ugis Gruntmanis

Get full text

Application of mean maximum Young’s modulus value as a new parameter for differential diagnosis of prostate diseases by Nailei Huang, Xinge Cao, Zhong Li, Haoyu Wang, Wei Zhao, Jun Shi

Subjects: “…Benign prostatic hyperplasia…”
Get full text

Asthma-associated prostate enlargement and bladder smooth muscle hypercontractility: unveiling a potential link to LUTS by Peibin Cen, Ming Chen, Xin Qiu, Wenbin Guo, Hongyu Lan, Xingyu Zhou, Ming Lei, Guohua Zeng, Qingfeng Yu

Subjects: Get full text

Hubungan Penurunan Kadar Natrium Terhadap Gangguan Pola Tidur Pasca TURP (Transurethral Resection of The Prostate) by Khomeini Khomeini, Dody E Dody E, Erkadius Erkadius

“…This study is a cross sectional study, all patients with diagnose Benign Prostate Hypertrophi should be check sodium level and get questionnaire sleep patterns disturbances. …”
Get full text

Comparison of intensity normalization methods in prostate, brain, and breast cancer multi-parametric magnetic resonance imaging by Savannah R. Duenweg, Samuel A. Bobholz, Allison K. Lowman, Aleksandra Winiarz, Biprojit Nath, Michael J. Barrett, Fitzgerald Kyereme, Stephanie Vincent-Sheldon, Peter LaViolette

Subjects: Get full text

Enhancing prostate cancer segmentation in bpMRI: Integrating zonal awareness into attention-guided U-Net by Chao Wei, Zheng Liu, Yibo Zhang, Lianhui Fan

“…Purpose Prostate cancer (PCa) is the second most common cancer in males worldwide, requiring improvements in diagnostic imaging to identify and treat it at an early stage. …”
Get full text

The Direct Healthcare Expenditures of Prostate Cancer by Disease Severity: Evidence from US National Survey Data by Peter J. Mallow, Jie Chen, John A. Rizzo, John R. Penrod, Geralyn C. Trudel, Teresa M. Zyczynski

“…**Background:** In the United States, approximately 2.8 million men have a history of prostate cancer (PC). **Objective:** This study quantified the effects of PC, overall and by disease severity on direct healthcare costs to insurers and patients. …”
Get full text

An Unusual Case of Resistant Hypokalaemia in a Patient with Large Bowel Obstruction Secondary to Neuroendocrine Carcinoma of the Prostate by Umasankar Mathuram Thiyagarajan, A. Ponnuswamy, A. Bagul, A. Gupta

“…Neuroendocrine Carcinoma of the Prostate (NECP) is rare and only few cases have been reported, constituting less than 0.5% of prostatic malignancies. …”
Get full text

Botulinum Neurotoxin Type A for the Treatment of Benign Prostatic Hyperplasia: Randomized Study Comparing Two Doses by René Arnouk, Carlos Henrique Suzuki Bellucci, Roberto Benatuil Stull, José de Bessa Junior, Cesar Augusto Malave, Cristiano Mendes Gomes

“…Men with symptomatic BPH who failed medical treatment were randomized to receive 100 U or 200 U of BoNT-A into the prostate. The International Prostatic Symptom Score (IPSS), maximum flow rate (Qmax), post-void residual volume (PVR), PSA levels and prostate volume before injection and after 3 and 6 months were evaluated. …”
Get full text

The potential of Curcuma longa L. bioactive compounds as RSK inhibitors for the treatment of prostate cancer: in silico study by Olusola Olalekan Elekofehinti, Foluso Adeola Taiwo, Moses Orimoloye Akinjiyan, Ifeoluwa Rachael Adetoyi, Folasade Oluwatobiloba Ayodeji, Adedotun Olayemi Oluwatuyi, Oluwapelumi Nifesimi Akintoye, Idayat Oyinkansola Kehinde, Bolanle Esther Adedapo, Opeyemi Iwaloye

Subjects: Get full text